InvestChile Promotes Pharmaceutical Companies Landing in South America's Business Hub
It was in response to this scenario that InvestChile, Chile's Foreign Investment Promotion Agency, together with the Public Health Institute (ISP), launched its new e-book "The pharmaceutical industry in Chile: Installed capacity, stakeholders, investment incentives" .
- It was in response to this scenario that InvestChile, Chile's Foreign Investment Promotion Agency, together with the Public Health Institute (ISP), launched its new e-book "The pharmaceutical industry in Chile: Installed capacity, stakeholders, investment incentives" .
- The e-book compiles information and provides details on the health authorities, the permits needed for medical establishments and studies, sanitary registration and regulations, and the benefits that foreign companies can access when investing in the sector in Chile.
- The document reveals that Chile's pharmaceutical industry moves around US $1.8 billion, equivalent to 0.73% of national GDP, and has a positive impact on other sectors of the economy, such as manufacturing, commerce, and transportation.
- Among the benefits that Chile represents for foreign pharmaceutical companies in search of an investment destination is the wide network of free trade agreements signed by the country, which favor exports and make it possible for companies to respond to the demand for pharmaceutical products in the region and around the world.